PD-L1 inhibitory effect of atorvastatin might benefit the cancer treatment since drugs inhibiting eIF4F–STAT1–PD-L1 axis mediates tumor regression in the murine melanoma model [39]. This evidence concerns the gene STAT1 and neoplasm.